ICMR to fund research in ‘immunology’ cure
The ICMR has asked research institutions including hospitals to participate in the funding round and it expects research activities to take off by June. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 highlighted vulnerabilities in medical manufacturing supply chain: Fitch
"We believe that over the longer term, govt may aim to source more key pharmaceutical ingredients locally as opposed to the current heavy reliance on China, and to a lesser degree India," it said. This provides an opportunity for the Indian govt to escalate domestic production of pharma ingredients to counteract an over-reliance on Chinese imports now hampered by COVID-19 shutdowns. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2020 Category: Pharmaceuticals Source Type: news

Hydrochloroquine not effective against COVID-19: Study
Hydrochloroquine - touted as a Covid "game-changer"- is not effective against the disease, a study has found. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

COVID-19: Novartis to begin HCQ trials
Even as there is still question hanging over the efficacy of hydroxychloroquine (HCQ) as medication for Covid-19, Swiss drug maker Novartis announced trials to evaluate use of HCQ for the treatment of hospitalised patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Avoid use of antibody tests for now: ICMR
The Indian Council of Medical Research on Tuesday advised states not to use the new rapid antibody test for Covid-19 from China till further notice after reports emerged that the kits are faulty. “The kits will be tested and validated in the field by our teams. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Export of anti-tuberculosis medicines a worry
The health ministry has flagged the need for suspension of the export of anti-tuberculosis medicines, saying the coronavirus outbreak has impacted domestic production of these drugs and their overseas shipment will worsen the supply problem in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

COVID-19: 16 companies get funds for R & D work
The department of biotechnology has granted funds to 16 companies for developing drugs, vaccines and devices to fight the Covid-19 pandemic as India looks to speed up the process of tackling the disease. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

FDA approves first in-home test for coronavirus
Patients will swab their own nose using a testing kit sent by the company and will mail it in an insulated package back to the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Baddi drug units feel side effects of virus curbs
Fifty pharmaceutical manufacturing facilities have shuttered their operations in Baddi, Himachal Pradesh, Asia ’s largest pharmaceutical hub, while others are operating at significantly reduced capacities after the region was declared a containment zone. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

India co-sponsors resolution calling for equitable access to COVID-19 vaccines
The 193-Member General Assembly adopted the Mexico-drafted resolution 'International cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19' by consensus on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Indian pharmaceutical firms will play important role in fight against COVID19 pandemic: Ambassador Taranjit Singh Sandhu
India, one of the largest producers of anti-malarial drug hydroxychloroquine, has seen a spurt in demand in recent weeks. India has sent the drug to over 50 countries over the last few days, including the United States, he said on Tuesday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus shuts door on other viruses, sales of many drugs fall
Sales of anti-infectives have fallen 34% month on month so far in April while sales of respiratory drugs (excluding asthma products) have dropped 20% and those of painkillers fell 27%, data from All India Organisation of Chemists and Druggists (AIOCD) show. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 20, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila takes a shot at old Hepatitis C injection to treat Covid-19
Ahmedabad-based Zydus has initiated talks with the Department of Biotechnology for a compassionate trial. It is also working with the USFDA to register the drug for “compassionate use programme”. The company has already registered the drug with the Indian drug controller for a trial approval. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 20, 2020 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets VAI classification from USFDA for Hyderabad unit
As per the USFDA, a VAI inspection classification indicates that although investigators found and documented objectionable conditions during the inspection, FDA will not take or recommend regulatory or enforcement action because the objectionable conditions do not meet the threshold for action at this time. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 20, 2020 Category: Pharmaceuticals Source Type: news

No symptoms in 80% of Covid cases raise concerns
The new revelation of asymptomatic or mildly symptomatic infection in India has sparked concerns. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 20, 2020 Category: Pharmaceuticals Source Type: news

Experts criticise India ’s endorsement for use of hydroxychloroquine on Covid-19 patients
In the absence of credible evidence, a blanket recommendation for chemoprophylaxis might be contentious, the experts said in an article published online by the Lancet on April 17. Prophylaxis refers to treatment given to prevent a disease. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 19, 2020 Category: Pharmaceuticals Source Type: news

View: Global leadership needed to push pharma solutions and distribute them at affordable prices
G7 meeting last month failed to agree on a statement on the pandemic, accentuating the group ’s continuing slide into irrelevance. The G20 Leaders Summit on March 26 called for “a transparent, robust, coordinated, large scale and science based global response in the spirit of solidarity”. However, the ground reality is that more than 75 countries have imposed trade restrictions on Cov id-19 related supplies since the beginning of the year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 19, 2020 Category: Pharmaceuticals Source Type: news

Strides receives USFDA approval for Flucytosine Capsules
The product is a generic version of Ancobon Capsules, 250 mg and 500 mg, of Bausch Health US, LLC, the Bengaluru- headquartered pharmaceutical company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 19, 2020 Category: Pharmaceuticals Source Type: news

Alembic gets USFDA nod for generic ophthalmic solution
Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 19, 2020 Category: Pharmaceuticals Source Type: news

DBT approves funding for three companies for developing coronavirus vaccine
The DBT said a multifaceted approach is being adopted to ensure that vaccine companies utilising different platforms and at different stages of development are fast tracked through a research consortium under funding from the National Biopharma Mission, an initiative launched in 2017 to support development of vaccines and drugs. ​ (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 19, 2020 Category: Pharmaceuticals Source Type: news

COVID-19: Drugs with less than 60% shelf life allowed to be imported on condition
According to rules, the import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the drug will be utilised or consumed before the expiry date and no part of it will be available for sale and distribution after its expiry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2020 Category: Pharmaceuticals Source Type: news

India sends hydroxychloroquine to UAE for COVID-19 patients
India has agreed to send hydroxychloroquine tablets to the United Arab Emirates to be used for treating COVID-19 patients, the Gulf Arab state's embassy in New Delhi said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2020 Category: Pharmaceuticals Source Type: news

Drug Controller General permits clinical trial of convalescent plasma in COVID-19 patients
The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol developed by ICMR. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod to market muscle spasms tablets
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Baclofen tablets in the strength of 5 mg, Zydus Cadila said in a statement. The product will be manufactured at the group's formulations manufacturing facility at Baddi, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2020 Category: Pharmaceuticals Source Type: news

Remove policy hurdles, grant infrastructure status to bulk drug industry: CII-KPMG report
The report, 'Indian API Industry- Reaching the Full Potential', by industry body CII and KPMG also recommended granting of infrastructure status to the bulk drug industry. India needs to proactively boost the manufacturing of APIs, intermediates and KSMs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Kerala Institute says it has a faster and cheaper test for COVID-19
A Kerala-based institute has developed a diagnostic test for Covid-19 which it claims can furnish results in less than half the time taken by the method currently being used in the country and for a fraction of its cost — ₹1,000. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Short of breath, Government to let in used ventilators
In a memorandum dated April 1, the ministry of environment, forest and climate change relaxed the import policy to facilitate use of second-hand ventilators by hospitals. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Antibody kits arrive from China, but only for surveillance
These kits, also known as serological testing kits, are not meant for early diagnosis or detection of the disease, said Raman Gangakhedkar, head of the department of epidemiology at the Indian Council of Medical Research. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Bayer's chloroquine donation to U.S. raises concern about FDA standards in pandemic
On Mar 21, two days after President Trump first touted chloroquine drugs as a "gamechanger" in the fight against COVID-19, administration officials privately described what they felt was a "win" in the President's efforts to build an emergency stockpile of the drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Collaborative effort key to find solution to Covid-19: Adar Poonawalla, CEO, Serum Institute of India
Addressing a webinar organised by Bennett University on ‘Combating Covid-19: Biotech to the Rescue’ on Thursday, he said patience and efficiency will be important during the development of the vaccine, although the general public expects a quick vaccine (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

US, India working jointly on Covid vaccine: Pompeo
Indicating that India and the US were cooperating beyond Covid, Pompeo said, significantly, “We’re paying attention to supply chains. We want to mesh the supply chains that both countries have access to in areas that are important for our national security.” (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Govt lifts curbs on exports of formulations made from Paracetamol
The government on March 3 had put export restrictions on 26 pharma ingredients and medicines, including paracetamol. However on April 6, it removed the export restrictions on 24 APIs and formulations excluding Paracetamol. However, restrictions on exports of Paracetamol active pharmaceutical ingredients (APIs or raw materials) will continue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Bajaj Healthcare gets Gujarat FDA nod to manufacture hydhroxychloroquine sulphate
​The company will commence production of hydhroxychloroquine sulphate API in the next 3 weeks at its Vadodara facility and it is estimated to produce 15 Mts of API per month, Bajaj Healthcare said. It has started the production of hydroxychloroquine FDF (tablets) at Vadodara unit and is expected to produce around 1.5 crore hydroxychloroquine sulphate tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2020 Category: Pharmaceuticals Source Type: news

Jubilant Life Sciences says no traces of Covid-19 in raw material imported to its Nanjangud facility
The press statement was issued in the backdrop of 49 cases employees of the pharma facility Jubilant Life Sciences in Nanjangud and their primary and secondary contacts testing positive for Covid-19 in the last couple of weeks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

India has capacity to be global hub for manufacturing test kits
Kiran Mazumdar-Shaw, executive chairperson, Biocon, speaking at a webinar held by the Department of Biotechnology, School of Engineering& Applied Sciences at the Bennett University, on Thursday on the theme “Combating Covid-19: Biotech to the Rescue”. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

Govt fastracks approval for industrial oxygen makers to produce medical oxygen
In view of the fast-spreading novel coronavirus infection, for which there is no vaccine, the World Health Organisation has advised all countries to work towards optimising the availability of pulse oximeters and medical oxygen systems. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

AIIMS taps robots and telemedicine to cut contact risk
The institute, ranked the best in the National Institute Ranking Framework by the government, is using robots to sanitise and clean the areas used by Covid-19 patients, including intensive care units. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

Testing efforts hit another hurdle as labs face shortage of VTMs
The latest bottleneck to confront the Indian healthcare system in scaling up molecular diagnostic testing for Covid-19 is shortage of tools and equipment needed to collect and transport samples called the viral transport mediums (VTM). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

Tens of thousands of Chinese PPE kits fail India safety test
India continues to see a shortfall in the availability of personal protection equipment (PPE) for healthcare even as the government significantly ramps up domestic production and some kits from China failed quality tests. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

Covid medicine: Dr Reddy ’s Laboratories begins work on Gilead drug clone
While scientists across the world are racing to develop drugs and vaccines against the coronavirus, remdesivir is among the few that have shown promise. Indian drugmaker Cipla said a few weeks ago that it was also working on the drug along with the state-run Council of Scientific and Industrial Research (CSIR). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

States get over 100 proposals for bulk drugs production after MoEF decentralises green nod process
To address the unprecedented situation arising from the global outbreak of COVID-19 and to ramp up availability or production of various drugs, the environment ministry (MoEF) had last month amended the Environment Impact Assessment (EIA) notification for expediting the environmental clearance for API-related projects, saying they will get the approval at the state level itself. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2020 Category: Pharmaceuticals Source Type: news

The world will need more than one COVID-19 vaccine, says GSK CEO
The world will need more than one COVID-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, said GlaxoSmithKline Chief Executive Officer Emma Walmsley. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2020 Category: Pharmaceuticals Source Type: news

India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19
India's decision to sell the sought-after drug to Malaysia signals a turnaround in relations between the countries that had soured because of repeated criticism of some Indian policies by Mahathir Mohamad, before he resigned as Malaysia's prime minister in February. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2020 Category: Pharmaceuticals Source Type: news

Six Indian companies working on COVID-19 vaccine, many challenges in finding a preventive: Experts
Nearly 70 'vaccine candidates' are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the novel coronavirus is unlikely to be ready for mass use before 2021. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2020 Category: Pharmaceuticals Source Type: news

Pharmacists to ration drugs to avoid shortage
Pharmacists in the country have decided to ration the sale of medicines to customers in a bid to curb panic buying and stave off a shortage in supplies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2020 Category: Pharmaceuticals Source Type: news

BCG vaccine not recommended for virus: WHO
The statement gains significance for countries including India, where some states are considering using the BCG vaccine for clinical trials on Covid-19 patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2020 Category: Pharmaceuticals Source Type: news

GSK, Sanofi team up to bring out Covid-19 vaccine
Two of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if it passes the clinical trials would become available by 2021. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2020 Category: Pharmaceuticals Source Type: news

Antibody test kits: After China issues, govt taps 3 nations
India has reached out to South Korea, Singapore and Switzerland to procure antibody rapid test kits due to a delay in supply from China over quality issues, sources in the government told ET. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 13, 2020 Category: Pharmaceuticals Source Type: news

ICMR may use remdesivir if local companies can manufacture it
The Indian Council of Medical Research (ICMR) said it will consider using remdesivir, an experimental drug made by Gilead Sciences, to treat Indian Covid-19 patients if domestic companies can manufacture it. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 13, 2020 Category: Pharmaceuticals Source Type: news

USFDA clears four Indian manufacturing plants in 10 days
India ’s leading drug companies have had their manufacturing facilities cleared in the last 10 days by the US Food and Drug Administration (USFDA), a decision that comes at a time when supply-chain disruptions due to the Covid-19 pandemic are causing drug shortages across the world. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 13, 2020 Category: Pharmaceuticals Source Type: news